ZHOU Min,LIU Xiu,WU Yongjun,et al.Mechanism of Astragaloside Ⅳ on db/db Mice with Type 2 Diabetes Mellitus and Non-alcoholic Fatty Liver Disease Based on AMPK Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(05):72-79.
ZHOU Min,LIU Xiu,WU Yongjun,et al.Mechanism of Astragaloside Ⅳ on db/db Mice with Type 2 Diabetes Mellitus and Non-alcoholic Fatty Liver Disease Based on AMPK Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(05):72-79. DOI: 10.13422/j.cnki.syfjx.20232039.
Mechanism of Astragaloside Ⅳ on db/db Mice with Type 2 Diabetes Mellitus and Non-alcoholic Fatty Liver Disease Based on AMPK Signaling Pathway增强出版
Molecular Mechanism of Action of Astragaloside Ⅳ in Modulating Pyroptosis to Attenuate Intestinal Ischemia-reperfusion Injury Based on Experimental Validation
Mechanism of Astragaloside Ⅳ in Treating Diabetic Retinopathy Based on Network Pharmacology and Molecular Docking
Molecular Mechanism of Resveratrol Against NAFLD Based on Network Pharmacology
Analysis on Mechanism of Astragali Radix in Treating IgA Nephropathy Based on Network Pharmacology and in Vitro Cell Experiment
Related Author
CHANG Liya
LENG Yufang
ZHAO Zicen
WANG Yu
XING Yang
LI Dongbin
Naixin YU
Guoqiong LI
Related Institution
The First Clinical Medical College of Lanzhou University
The First Hospital of Lanzhou University
The Institute of Medicinal Plant Development,Chinese Academy of Medical Sciences and Peking Union Medical College
School of Pharmacy,Guangdong Pharmaceutical University
School of Life Sciences and Biopharmaceutics,Guangdong Pharmaceutical University